Proton-pump inhibitors and hypomagnesemic hypoparathyroidism [14]

New England Journal of Medicine

Volumn 355, Issue 17, 2006, Pages 1834-1836

  Epstein, Martin ^a   McGrath, Shaun ^a   Law, Florence ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; ESOMEPRAZOLE; MAGNESIUM; OMEPRAZOLE; PARATHYROID HORMONE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGED; ANAMNESIS; BARRETT ESOPHAGUS; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL BIOPSY; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; LETTER; MAGNESIUM BLOOD LEVEL; MALE; MUSCLE SPASM; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

AGED, 80 AND OVER; ANTI-ULCER AGENTS; CALCIUM; FEMALE; HUMANS; HYPOPARATHYROIDISM; MAGNESIUM; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS;

EID: 33750320388     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc066308     Document Type: Letter

References (1)

1. Subbiah V, Tayek JA. Tetany secondary to the use of a proton-pump inhibitor. Ann Intern Med 2002;137:E219.